Delayed
Bombay S.E.
01:58:48 2024-06-05 am EDT
|
5-day change
|
1st Jan Change
|
346
INR
|
+0.41%
|
|
-1.35%
|
-5.98%
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
600
|
549.5
|
998.5
|
3,000
|
3,905
|
Enterprise Value (EV)
1 |
742.7
|
626.7
|
1,160
|
3,259
|
4,014
|
P/E ratio
|
12.1
x
|
17.7
x
|
36.6
x
|
47.6
x
|
108
x
|
Yield
|
-
|
-
|
-
|
0.57%
|
0.44%
|
Capitalization / Revenue
|
0.43
x
|
0.45
x
|
0.69
x
|
0.97
x
|
1.18
x
|
EV / Revenue
|
0.53
x
|
0.52
x
|
0.8
x
|
1.05
x
|
1.21
x
|
EV / EBITDA
|
8.71
x
|
8.12
x
|
16.8
x
|
24.9
x
|
38.8
x
|
EV / FCF
|
-5.36
x
|
11.5
x
|
-10.2
x
|
-46.4
x
|
27.4
x
|
FCF Yield
|
-18.7%
|
8.73%
|
-9.78%
|
-2.16%
|
3.65%
|
Price to Book
|
1.73
x
|
1.45
x
|
2.48
x
|
6.45
x
|
8.07
x
|
Nbr of stocks (in thousands)
|
11,500
|
11,500
|
11,500
|
11,500
|
11,500
|
Reference price
2 |
52.17
|
47.78
|
86.83
|
260.9
|
339.6
|
Announcement Date
|
8/20/19
|
9/3/20
|
7/10/21
|
6/15/22
|
8/4/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
946
|
1,410
|
1,215
|
1,452
|
3,104
|
3,306
|
EBITDA
1 |
59.97
|
85.27
|
77.14
|
69.1
|
131.1
|
103.6
|
EBIT
1 |
42.32
|
67.64
|
49.58
|
45.7
|
97.63
|
63.58
|
Operating Margin
|
4.47%
|
4.8%
|
4.08%
|
3.15%
|
3.15%
|
1.92%
|
Earnings before Tax (EBT)
1 |
37.85
|
56.17
|
40.76
|
41.5
|
84.84
|
47.64
|
Net income
1 |
24.79
|
41.83
|
31.04
|
27.3
|
63.05
|
36.14
|
Net margin
|
2.62%
|
2.97%
|
2.56%
|
1.88%
|
2.03%
|
1.09%
|
EPS
2 |
3.079
|
4.319
|
2.696
|
2.374
|
5.480
|
3.140
|
Free Cash Flow
1 |
4.836
|
-138.7
|
54.7
|
-113.4
|
-70.3
|
146.6
|
FCF margin
|
0.51%
|
-9.83%
|
4.5%
|
-7.81%
|
-2.27%
|
4.43%
|
FCF Conversion (EBITDA)
|
8.06%
|
-
|
70.92%
|
-
|
-
|
141.52%
|
FCF Conversion (Net income)
|
19.51%
|
-
|
176.24%
|
-
|
-
|
405.6%
|
Dividend per Share
|
-
|
-
|
-
|
-
|
1.500
|
1.500
|
Announcement Date
|
8/20/18
|
8/20/19
|
9/3/20
|
7/10/21
|
6/15/22
|
8/4/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
162
|
143
|
77.2
|
161
|
259
|
109
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
2.697
x
|
1.674
x
|
1.001
x
|
2.336
x
|
1.974
x
|
1.048
x
|
Free Cash Flow
1 |
4.84
|
-139
|
54.7
|
-113
|
-70.3
|
147
|
ROE (net income / shareholders' equity)
|
19.8%
|
17.3%
|
8.57%
|
7.03%
|
14.5%
|
7.62%
|
ROA (Net income/ Total Assets)
|
6.87%
|
9.27%
|
5.99%
|
5.25%
|
8.67%
|
5.39%
|
Assets
1 |
360.8
|
451.4
|
517.8
|
520.4
|
727
|
670.6
|
Book Value Per Share
2 |
17.10
|
30.10
|
32.80
|
35.00
|
40.40
|
42.10
|
Cash Flow per Share
2 |
0.3900
|
0.3800
|
0.5000
|
0.4100
|
0.0800
|
2.880
|
Capex
|
-
|
75.1
|
8.11
|
59.7
|
74.4
|
31.2
|
Capex / Sales
|
-
|
5.32%
|
0.67%
|
4.11%
|
2.4%
|
0.95%
|
Announcement Date
|
8/20/18
|
8/20/19
|
9/3/20
|
7/10/21
|
6/15/22
|
8/4/23
|
|
1st Jan change
|
Capi.
|
---|
| -5.98% | 47.44M | | +18.74% | 67.26B | | -1.64% | 48.54B | | +22.36% | 44.21B | | +27.53% | 28.1B | | +7.42% | 19.23B | | +11.10% | 16.84B | | -6.51% | 15.86B | | -27.02% | 14.76B | | -18.11% | 13.9B |
Other Specialty Chemicals
|